Lecture 13/14: Tumors, Transplants/Immunodeficiency Flashcards

(31 cards)

1
Q

4 mechanisms of tumor immune evasion

A
  1. Failure to produce tumor Ags
  2. MHC I deficiency
  3. Secretion of inhibitory proteins
  4. Expression of inhibitory cell surface proteins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Enhancing tumor immunity

A

Passive: mAb, autologous T cell transfer
Adaptive: Chimeric Ag Receptor T cells
Chkpt: anti-CTLA-4, anti-PD-1/anti-PD-L1
Combo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Immunological approaches to cancer

A
  • Prevent
  • Passive immunization
  • Adaptive T cell therapy
  • Immune chkpt blocking
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Transplant immunology

A

Syngeneic = identical genes
Allogeneic = same species, diff. individual
Xenogeneic = diff. species
Autologous = to/from self

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

MHC transplant Ags

A

MHC has several antigenic sites that recipient T cells may recognize as foreign or recognize alloMHC::self peptide as selfMHC::foreign peptide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Transplant immune response

A
  1. AlloAg transport to LNs
  2. T cell activation, expansion, migration
  3. Inflam. cytokine secretion
  4. Graft cell killing -> rejection (direct vs indirect)
    - Direct: donor MHC recognized
    - Indirect: alloAg is processed
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Types of graft rejection

A
  1. Hyperacute
    - W/in minutes; Abs recognize endothelial Ags -> complement, coag. -> ischemia
  2. Acute
    - Days to wks; graft alloAg processing -> Abs/T cells
  3. Chronic
    - Months to yrs; alloreactive T cells -> chronic inflam. -> arteriosclerosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Methods to prevent transplant rejection

A
  • HLA type matching
  • Immunosuppression
  • Therapies vs Ab mediated rejection (steroids, anti-thymocyte globulin, soluble CTLA-4)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Agglutination between blood types

A

ABO Ags define blood groups; recognition of allo-Abs -> agglutination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Graft versus host disease

A

Occurs after HSC transplant i.e. bone marrow
- Mature T cells from graft attack host; similar to T cell autoimmunity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Types of immunodeficiencies

A
  1. Primary (congenital)
  2. Secondary (acquired
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Primary (congenital) immunodeficiency

A
  • Caused by gene defects, rare, inherited
  • Present early
  • Usually autosomal recess. or X-linked
  • Suscept. to recurrent infections, viral cancers

Common defects = lymphocyte maturation/activation, effector defects
- Many req. bone marrow transplant
- Maternal IgG protects for first 6 months of life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Chronic Granulomatous Disease (CGD)

A

Primary innate immune deficit
- Phagocyte oxidase complex Mx -> reduced ROS production -> inhib. pathogen killing
- Granulomas form due to recognition w/o degradation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Leukocyte Adhesion Deficiency (LAD)

A

Primary innate immune deficit
- Cell trafficking defect
- LAD-1 Mx -> CD18 (integrin beta chain)
- LAD-2 Mx -> E/P-selectin ligand defect
- Issues w/ transport to infection sites or LNs
- Increased WBC count

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Complement deficiencies

A

Primary innate immune deficit
- C3 gene Mx -> no functional complement pathways
- Suscept. to pyogenic bacteria (opsonization), Neisseria infections (MAC)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Primary adaptive defects in lymphocyte maturation

A
  • SCID
  • Bare lymphocyte syndrome
  • DiGeorge’s Syndrome
17
Q

SCID

A

Severe Combined ImmunoDeficiency
- Loss of T+B cell function
- B cell functional defect may be secondary to T cells

  1. X-linked
  2. Autosomal recessive
18
Q

X-linked SCID

A
  • Mx in cytokine R gamma chain gene -> signal tranduction defect for many cytokines
  • T/NK cell deficiency w/ secondary humoral deficiency
19
Q

Autosomal recessive SCID

A

Secondary to ADA, PNP deficiency OR to RAG1/2 Mx
- Adenosine deaminase
- Purine Nucleoside Phosphorylase
Toxic purine metabolite buildup -> dividing T cell loss -> secondary B deficit

20
Q

Bare Lymphocyte Syndrome

A

MHC II Mx -> no MHC II; lymphocytes nonfunctional

21
Q

DiGeorge’s Syndrome

A

Fetal developmental defect -> complete/partial missing thymus
- T cell defect, normal B cells

22
Q

Primary B cell defects

A
  1. X-linked agammaglobulinemia
  2. X linked hyper IgM syndrome
23
Q

X-linked agammaglobulinemia

A
  • BTK defect -> B cell maturation failure
24
Q

X-linked hyper IgM syndrome

A

CD40L Mx -> no class switching; nearly all Abs stay IgM

25
Secondary (acquired) immunodeficiencies
- Autoimmune anti-cytokine Abs - HIV
26
HIV
Reverse transcriptase RNA virus - gp120, gp41 entry to APCs - Hijack cell to make HIV virions
27
HIV progression
1. Most common. DC init. infection -> transport to LNs 2. Acute infection phase - Init. lymphoid tissue immune response 3. Clinical latency - Func. immune sys., no symptoms - Slow CD4+ destruction (months-yrs) 4. Chronic progressive infection -> AIDS
28
HIV screening methods
Method based on timing; products vary over time - 10-30 days post infection: p24, Ab screening - Early: nucleic acid testing, IgM/IgG to HIV
29
Highly Active Anti-Retroviral Therapy (HAART)
Combo therapy to multiple HIV steps - CD4+ attachment - CCR5/CXCR4 binding - Memb. fusion - Reverse transcriptase - HIVE integrase
30
Pre-Exposure Prophylaxis
PrEP RT inhibs. -> prevent viral replication in init. negative patient
31
Graft rejection drugs